| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hively Brad | Director | C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS | /s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively | 05 Jun 2025 | 0001891124 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TOI | Common Stock | Options Exercise | $581,849 | +684,528 | +96% | $0.8500 | 1,396,561 | 03 Jun 2025 | Direct | |
| transaction | TOI | Common Stock | Options Exercise | $50,659 | +105,320 | +7.5% | $0.4810 | 1,501,881 | 03 Jun 2025 | Direct | |
| transaction | TOI | Common Stock | Options Exercise | $245,525 | +131,297 | +8.7% | $1.87 | 1,633,178 | 03 Jun 2025 | Direct | |
| transaction | TOI | Common Stock | Options Exercise | $804,491 | +946,460 | +58% | $0.8500 | 2,579,638 | 03 Jun 2025 | Direct | |
| transaction | TOI | Common Stock | Sale | $5,360,587 | -1,867,605 | -72% | $2.87 | 712,033 | 03 Jun 2025 | Direct | |
| transaction | TOI | Common Stock | Sale | $311,519 | -108,532 | -15% | $2.87 | 603,501 | 03 Jun 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TOI | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | +684,528 | $0.000000 | 0 | 03 Jun 2025 | Common Stock | 684,528 | $0.8500 | Direct | F2, F6 | |
| transaction | TOI | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | +105,320 | $0.000000 | 0 | 03 Jun 2025 | Common Stock | 105,320 | $0.4810 | Direct | F3, F6 | |
| transaction | TOI | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | +131,297 | $0.000000 | 0 | 03 Jun 2025 | Common Stock | 131,297 | $1.87 | Direct | F4, F6 | |
| transaction | TOI | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | +946,460 | $0.000000 | 0 | 03 Jun 2025 | Common Stock | 946,460 | $0.8500 | Direct | F5, F6 |
| Id | Content |
|---|---|
| F1 | Represents sale of Common Stock acquired from previously vested RSU awards. |
| F2 | These options vested monthly for 36 months following November 12, 2021. |
| F3 | These options vested monthly starting March 17, 2023, with cancellation of remaining options pursuant to Note 6 below. |
| F4 | These options vested monthly starting November 17, 2022, with cancellation of remaining options pursuant to Note 6 below. |
| F5 | These options vested monthly for 48 months following December 2, 2019. |
| F6 | Pursuant to a Transition Agreement with the Reporting Person, all unvested options were cancelled after June 30, 2024. |